Physician profile
Naureen Ali
NPI 1487036547
$3,633.51
in general payments reported to CMS, 2019-2025
35 companies · $198 in 2025
The $198 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,207 · 2023: $1,411 · 2024: $817 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,426.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,426.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $375.10 | 2022-2025 | Mounjaro, Trulicity, Zepbound |
| Abbvie INC. | $342.19 | 2022-2025 | Vraylar |
| Novo Nordisk INC | $310.64 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $282.71 | 2022-2025 | Shingrix, Arexvy, Bexsero |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $212.46 | 2022-2024 | Xifaxan, Plenvu |
| Merck Sharp & Dohme LLC | $190.44 | 2022-2023 | Verquvo, Belsomra, Lagevrio |
| Amgen INC. | $152.37 | 2022-2024 | Evenity, Prolia, Krystexxa |
| Astellas Pharma US INC | $140.88 | 2022-2023 | Myrbetriq, Veozah |
| Janssen Pharmaceuticals, INC | $127.81 | 2022-2024 | Xarelto |
| Exact Sciences Corporation | $125.37 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $111.09 | 2022-2024 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $108.88 | 2022-2024 | |
| Organogenesis INC. | $108.23 | 2023-2024 | Puraply |
| Lundbeck LLC | $93.73 | 2022-2024 | Rexulti |
| Edwards Lifesciences Corporation | $87.52 | 2022-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
Show all 35 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naureen Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.